Does TOCILIZUMAB Cause Respiratory tract infection? 279 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 279 reports of Respiratory tract infection have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.3% of all adverse event reports for TOCILIZUMAB.
279
Reports of Respiratory tract infection with TOCILIZUMAB
0.3%
of all TOCILIZUMAB reports
48
Deaths
102
Hospitalizations
How Dangerous Is Respiratory tract infection From TOCILIZUMAB?
Of the 279 reports, 48 (17.2%) resulted in death, 102 (36.6%) required hospitalization, and 33 (11.8%) were considered life-threatening.
Is Respiratory tract infection Listed in the Official Label?
Yes, Respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for TOCILIZUMAB.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Respiratory tract infection?
RITUXIMAB (1,058)
PREDNISONE (1,051)
OMALIZUMAB (927)
ADALIMUMAB (913)
METHOTREXATE (895)
ETANERCEPT (848)
HUMAN IMMUNOGLOBULIN G (764)
LENALIDOMIDE (731)
DEXAMETHASONE (684)
ALBUTEROL (601)
Which TOCILIZUMAB Alternatives Have Lower Respiratory tract infection Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE